17β-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 583-590

  Russo, Rossella ^a   Cavaliere, Federica ^a   Watanabe, Chizuko ^b   Nucci, Carlo ^c   Bagetta, Giacinto ^a   Corasaniti, Maria Tiziana ^c,d   Sakurada, Shinobu ^b   Morrone, Luigi Antonio ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

estrogens; excitotoxicity; glaucoma; microdialysis; neuroprotection; oxidative stress

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; GLUTAMIC ACID; ANTIESTROGEN; DRUG DERIVATIVE; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CLOSED ANGLE GLAUCOMA; CONTROLLED STUDY; GLAUCOMA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINA ISCHEMIA; REVIEW; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CELLS, CULTURED; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; GLAUCOMA; GLUTAMIC ACID; INTRAOCULAR PRESSURE; MALE; NEURONS; RATS; RATS, WISTAR; RETINAL GANGLION CELLS;

EID: 53049099287     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01144-8     Document Type: Review

References (29)

1. Adachi K., Kashii S., Masai H., Ueda M., Morizane C., Kaneda K., Kume T., Akaike A., and Honda Y. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch. Clin. Exp. Ophthalmol. 236 (1998) 766-774
2. Amantea D., Russo R., Bagetta G., and Corasaniti M.T. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 52 (2005) 119-132
3. Casson R.J. Possible role of excitotoxicity in the pathogenesis of glaucoma. Clin. Exp. Ophthalmol. 34 (2006) 54-63
4. Clark J.H., and Markaverich B.M. The agonistic and antagonistic effects of short acting estrogens: a review. Pharmacol. Ther. 21 (1983) 429-453
5. Garcia-Segura L.M., Azcoitia I., and DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60
6. Goodman Y., Bruce A.J., Cheng B., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66 (1996) 1836-1844
7. Joo C., Cho K., Kim H., Choi J.S., and Oh Y.J. Protective role for bcl-2 in experimentally induced cell death of bovine corneal endothelial cells. Ophthalmic Res. 31 (1999) 287-296
8. Kumar D.M., Perez E., Cai Z.Y., Aoun P., Brun-Zinkernagel A.M., Covey D.F., Simpkins J.W., and Agarwal N. Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity. Free Radic. Biol. Med. 38 (2005) 1152-1163
9. Lubahn D.B., McCarty Jr. K.S., and McCarty Sr. K.S. Electrophoretic characterization of purified bovine, porcine, murine, rat, and human uterine estrogen receptors. J. Biol. Chem. 260 (1985) 2515-2526
10. Luo X., Lambrou G.N., Sahel J.A., and Hicks D. Hypoglycemia induces general neuronal death, whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2695-2705
11. Maggi A., Ciana P., Belcredito S., and Vegeto E. Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu. Rev. Physiol. 66 (2004) 291-313
12. Muller A., Maurin L., and Bonne C. Free radicals and glutamate uptake in the retina. Gen. Pharmacol. 30 (1998) 315-318
13. Nakazawa T., Takahashi H., and Shimura M. Estrogen has a neuroprotective effect on axotomized RGCs through ERK signal transduction pathway. Brain Res. 1093 (2006) 141-149
14. Nucci C., Tartaglione R., Rombolà L., Morrone L.A., Fazzi E., and Bagetta G. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 26 (2005) 935-941
15. Osborne N.N., Casson R.J., Wood J.P., Childlow G., Graham M., and Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23 (2004) 91-147
16. Osborne N.N., Ugarte M., Chao M., Childlow G., Bae J.H., Wood J.P., and Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43 Suppl 1 (1999) s102-s128
17. Pawlak J., Brito V., Kuppers E., and Beyer C. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res. Mol. Brain Res. 138 (2005) 1-7
18. Quigley H.A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80 (1996) 389-393
19. Richards D.A., Morrone L.A., Bagetta G., and Bowery N.G. Effects of α-dendrotoxin and dendrotoxin k on extracellular excitatory amino acids and on electroencephalograph spectral power in the hippocampus of anaesthetised rats. Neurosci. Lett. 293 (2000) 183-186
20. Simpkins J.W., and Dykens J.A. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res. Rev. 57 (2008) 421-430
21. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., and Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19 (1999) 2455-2463
22. Singer C.A., Rogers K.L., Strickland T.M., and Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212 (1996) 13-16
23. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 25 (2006) 490-513
24. Tezel G., Yang X., and Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3177-3187
25. Weaver Jr. C.E., Park-Chung M., Gibbs T.T., and Farb D.H. 17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761 (1997) 338-341
26. Wise P. Estradiol exerts neuroprotective actions against ischemic brain injury: insights derived from animal models. Endocrine 21 (2003) 11-15
27. Yang S.H., Liu R., Wu S.S., and Simpkins J.W. The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Ann. N.Y. Acad. Sci. 1007 (2003) 101-107
28. Zaulyanov L.L., Green P.S., and Simpkins J.W. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens. Cell. Mol. Neurobiol. 19 (1999) 705-718
29. Zhou X., Li F., Ge J., Sarkisian Jr. S.R., Tomita H., Zaharia A., Chodosh J., and Cao W. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Dev. Neurobiol. 67 (2007) 603-616